Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × BO-112 × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1

Interventions

pembrolizumab 539 Specimen Handling 503 Magnetic Resonance Spectroscopy 435 Carboplatin 349 Cyclophosphamide 331 Biopsy 303 Cisplatin 295 Paclitaxel 264 Nivolumab 250 Gemcitabine 227 Radiotherapy 221 Bevacizumab 192 Dexamethasone 190 fludarabine 183 venetoclax 177 Oxaliplatin 158 Docetaxel 156 Fluorouracil 153 atezolizumab 151 durvalumab 149 Rituximab 147 Capecitabine 143 Pemetrexed 141 Doxorubicin 133 Radiation 130 Lenalidomide 128 Prednisone 123 Standard of Care 121 Radiosurgery 118 Drug Therapy 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡